| # | Drug | Count |
|---|---|---|
| 0 | DARBEPOETIN ALFA | 174 |
| 1 | FUROSEMIDE | 51 |
| 2 | LANSOPRAZOLE | 49 |
| 3 | OMEPRAZOLE MAGNESIUM | 36 |
| 4 | ESOMEPRAZOLE MAGNESIUM | 35 |
| 5 | PANTOPRAZOLE | 27 |
| 6 | AMLODIPINE | 25 |
| 7 | EPOETIN ALFA | 25 |
| 8 | INSULIN GLARGINE | 23 |
| 9 | ATORVASTATIN CALCIUM | 22 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SODIUM CITRATE AND CITRIC ACID | 1 | 0.0208 |
| 1 | DAPRODUSTAT | 14 | 0.0070 |
| 2 | DOXERCALCIFEROL | 1 | 0.0060 |
| 3 | TOREMIFENE CITRATE | 2 | 0.0046 |
| 4 | IBALIZUMAB | 2 | 0.0037 |
| 5 | GADODIAMIDE | 12 | 0.0036 |
| 6 | SEVELAMER HYDROCHLORIDE | 2 | 0.0035 |
| 7 | DARBEPOETIN ALFA | 174 | 0.0032 |
| 8 | CARGLUMIC ACID | 2 | 0.0027 |
| 9 | VECURONIUM BROMIDE | 4 | 0.0026 |
| # | Drug class | Count |
|---|---|---|
| 0 | Erythropoiesis-stimulating Agent [EPC] | 174 |
| 1 | Corticosteroid [EPC] | 57 |
| 2 | Loop Diuretic [EPC] | 56 |
| 3 | Proton Pump Inhibitor [EPC] | 55 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 52 |
| 5 | Insulin Analog [EPC] | 43 |
| 6 | Dihydropyridine Calcium Channel Blocker [EPC] | 40 |
| 7 | Benzodiazepine [EPC] | 25 |
| 8 | Calcium Channel Blocker [EPC] | 25 |
| 9 | beta-Adrenergic Blocker [EPC] | 22 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 14 | 0.0062 |
| 1 | CD4-directed Blocking Antibody [EPC] | 2 | 0.0037 |
| 2 | Erythropoiesis-stimulating Agent [EPC] | 174 | 0.0032 |
| 3 | Carbamoyl Phosphate Synthetase 1 Activator [EPC] | 2 | 0.0027 |
| 4 | Paramagnetic Contrast Agent [EPC] | 12 | 0.0026 |
| 5 | Thyroid Stimulating Hormone [EPC] | 2 | 0.0019 |
| 6 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] | 14 | 0.0014 |
| 7 | Vitamin D2 Analog [EPC] | 10 | 0.0014 |
| 8 | Dihydrofolate Reductase Inhibitor Antimalarial [EPC] | 1 | 0.0008 |
| 9 | Sulfonamide Antibacterial [EPC] | 3 | 0.0008 |